JRJoris Ramstein

Joris Ramstein

*This is an algorithmically generated author record based on publicly available information.

Joris Ramstein has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Case Report of an Aggressive Angiomyxoma Presenting as Pelvic Organ Prolapse

    by Joris Ramstein, Charlotte Ter Haar, Noelani Guaderrama, Audai Alrwashdeh, Jennifer Lee

    Aggressive angiomyxoma (AAM) is a rare, slow‐growing, locally infiltrative mesenchymal tumor of the pelvis and perineum, most often affecting women. Its nonspecific presentation and tendency to mimic more common vaginal or periurethral masses frequently delay diagnosis. Early recognition is critical to guide appropriate surgical planning, optimize resection, and reduce recurrence risk. In this case, a 61‐year‐old woman with prior vaginal hysterectomy presented with symptoms of pelvic organ prolapse, urinary incontinence, and occasional bleeding. Examination revealed a 10 × 3‐cm protruding anterior vaginal wall mass with a spongy texture. MRI demonstrated a well‐defined tubular lesion in the left distal vaginal wall extending towards the vulva. Intraoperative evaluation, including cystourethroscopy, diagnostic laparoscopy, and general surgery consultation, ruled out bowel involvement. The mass was excised via vaginal approach with preservation of surrounding structures. Histopathology confirmed AAM. Margins could not be assessed due to specimen disruption. At 6‐week follow‐up, the patient was asymptomatic with well‐healed incisions, and ongoing surveillance with gynecologic oncology was arranged. This case highlights the importance of including AAM in the differential diagnosis of anterior vaginal wall masses. Multidisciplinary collaboration and advanced imaging are essential for accurate diagnosis and surgical planning. Given the tumor′s locally infiltrative nature and high recurrence rate, long‐term follow‐up is warranted. Awareness of this rare pathology can aid timely recognition and improve patient outcomes.

  • Open Access

    Pudendal block for the treatment of chronic pelvic pain: A randomized control trial

    by Joris Ramstein, Danielle Markle Price, Amneh Al Saleh, Felicia Lane

    Introduction: Chronic pelvic pain (CPP) affects up to 40% of reproductive-age women and often involves myofascial pelvic pain syndrome (MPPS), a musculoskeletal condition associated with pelvic floor dysfunction. Effective treatment options are limited, and pudendal nerve blocks have been proposed as an adjunct to pelvic floor physical therapy (PFPT). This study aimed to evaluate the impact of adding pudendal nerve blocks to PFPT on pain reduction and quality of life in patients with MPPS. Methods: This prospective, randomized, double-blind trial enrolled women with MPPS referred for PFPT. Participants were randomized to receive either pudendal nerve blocks with local anesthetic and steroid or placebo saline injections weekly for 6 weeks. The primary outcome was pain measured using a visual analog scale (VAS) at 8 weeks. Secondary outcomes included muscle tenderness, pelvic floor strength, and quality-of-life metrics (PFDI, PFIQ, SF-36, and FSFI). Statistical analyses included paired t -tests and mixed-model analysis for repeated measures. Results: Both groups experienced significant improvements in VAS scores ( p < 0.001) and muscle tenderness ( p = 0.003), with no significant differences between the groups ( p = 0.7, p = 0.15). As pain and tenderness decreased, patients reported increased pelvic floor strength, reduced distress, and improved quality of life by week 8. Conclusions: While pudendal blocks did not significantly enhance outcomes over placebo injections, PFPT alone likely drove the observed improvements in pain and quality of life. Future studies with larger sample sizes and additional comparison groups are needed to explore the potential role of adjunctive therapies in managing MPPS.


  • Factors Influencing Treatment Strategy for Overactive Bladder in the National Institute of Health All of Us Research Program

    by Joris Ramstein, Seyedeh Neelufar Payrovnaziri, Heike Thiel de Bocanegra, Jenny Chang, Argyrios Ziogas, Dena Moskowitz

    Importance: Overactive bladder (OAB) is a condition characterized by urinary urgency, frequency, and incontinence, affecting up to 43% of women. While treatment disparities are well-documented, this study sheds light on broader systemic barriers and the need for equitable approaches to improve diagnosis and management. Objective: This study aimed to examine the types of OAB treatments (no treatment, pharmacotherapy, advanced therapy) received by patients in the United States, stratified by race, ethnicity, and socioeconomic factors, using data from the All of Us Research Hub. Study Design: Data were collected from 20,941 female patients diagnosed with OAB in the All of Us Research Hub. Patients were categorized into 3 treatment groups: (1) no treatment, (2) pharmacotherapy, or (3) advanced therapy. Demographic factors such as race, ethnicity, age, income, and health status were analyzed using univariate and multivariate logistic regression models to determine the influence on treatment type. Results: Of the participants, 71% received no treatment, 27% were treated with pharmacotherapy, and 2% underwent advanced therapy. On multivariate analysis, Asian and Hispanic patients were less likely to receive pharmacotherapy compared to White patients (odds ratio (95% CI), 0.47 (0.31–0.72) and 0.84 (0.74–0.95) respectively). Additionally, factors such as increasing age, unemployment, and lower income were associated with greater odds of receiving pharmacotherapy. Conclusions: Significant differences exist in the treatment of OAB, particularly among Asian and Hispanic patients. Socioeconomic factors and self-reported health status also affect access to treatment. Addressing these disparities is crucial to improving health care equity and access for patients with OAB.


  • Open Access

    Patient Satisfaction in a Safety Net Urology Clinic

    by Christi Butler, Avi S. Baskin, Nnenaya A. Mmonu, Andrew J. Cohen, German Patino, Yi Li, Anthony Enriquez, Joris Ramstein, Benjamin N. Breyer

    Introduction: Patient satisfaction has become an important metric in medicine. In this study, we aim to identify modifiable factors contributing toward poor satisfaction amongst patients in a safety net urology clinic. We hypothesize that wait times and long distances traveled to clinic will have the largest contribution toward negative patient experiences. Methods: We conducted a cross-sectional study of adult patients presenting to the urology clinic at Zuckerberg San Francisco General Hospital. Participants completed a survey using the RAND Patient Satisfaction Questionnaire-18 after their clinic visit. Associations among demographic factors, wait times, use of a translator and satisfaction were examined. Results: Two hundred patients, 19 to 90 years old (median age 62), were enrolled. Overall, 65% of patients were satisfied with their experience in our clinic. Our results demonstrated a significant association among race, language and overall satisfaction scores (p=0.009 and p=0.003, respectively). Multivariable analysis showed that those who waited more than an hour to see a physician were less satisfied compared with those who waited less than 15 minutes (OR 0.25, 95% CI 0.08–0.74). Similarly, those who used a translator were less satisfied than those who did not use a translator (OR 0.29, 95% CI 0.08–1.01). Conclusions: In a safety net urology clinic, language differences and wait times may contribute to poor patient satisfaction. Future efforts toward improving language interpreter functionality and decreasing patient wait times will likely improve patient satisfaction.


  • Tyrosine Kinase Inhibitors and Male Reproductive Health

    by Joris J. Ramstein, Katy K. Tsai, James F. Smith

    Tyrosine kinase inhibitors (TKIs) are a targeted class of cancer therapies effective against a range of malignancies and their use is growing significantly each year. Many men taking TKIs desire children, yet very little is known about the potential for reproductive harm of these medications. The mechanism of action of TKIs suggest a possible route to impairment of sperm functional properties or spermatogenesis.


  • Ethical, moral, and theological insights into advances in male pediatric and adolescent fertility preservation

    by J. J. Ramstein, J. Halpern, A. J. Gadzinski, R. E. Brannigan, J. F. Smith

    Summary: The successful treatment of boys with cancer has led to increasing attention to preserving their quality of life after completing cancer therapy. One of the top priorities for living a full life is keeping open the opportunity to have children. While sperm banking for males facing sterilizing cancer treatment can be effective, this approach requires subsequent use of reproductive procedures such as in vitro fertilization (IVF) or intrauterine insemination (IUI) to achieve a pregnancy. Advances in fertility preservation techniques may allow pre‐pubertal boys to conceive using advanced stem cell technologies and stem cell transplantation in the future. This review summarizes the ethical positions of leading medical societies and explores the religious and moral stances of major religious institutions regarding these options.